Proto Labs CFO Departs, Interim Appointed

Ticker: PRLB · Form: 8-K · Filed: May 24, 2024 · CIK: 1443669

Proto Labs Inc 8-K Filing Summary
FieldDetail
CompanyProto Labs Inc (PRLB)
Form Type8-K
Filed DateMay 24, 2024
Risk Levelmedium
Pages3
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: executive-departure, cfo, interim-appointment

Related Tickers: PRLB

TL;DR

CFO Robert Foster is out at Proto Labs, Dale Johnson steps in as interim. Transition period until June 14.

AI Summary

Proto Labs, Inc. announced on May 23, 2024, the departure of its Chief Financial Officer, Robert W. Foster. The company has appointed Dale L. Johnson as the interim CFO. Foster will remain with the company until June 14, 2024, to ensure a smooth transition.

Why It Matters

The departure of a CFO can signal changes in financial strategy or performance, and the appointment of an interim suggests a search for a permanent replacement is underway.

Risk Assessment

Risk Level: medium — A CFO departure can indicate underlying financial issues or strategic shifts, creating uncertainty for investors.

Key Players & Entities

  • Proto Labs, Inc. (company) — Registrant
  • Robert W. Foster (person) — Departing Chief Financial Officer
  • Dale L. Johnson (person) — Interim Chief Financial Officer
  • May 23, 2024 (date) — Date of Report
  • June 14, 2024 (date) — Robert W. Foster's last day

FAQ

Who is the new interim Chief Financial Officer for Proto Labs, Inc.?

Dale L. Johnson has been appointed as the interim Chief Financial Officer for Proto Labs, Inc.

When is Robert W. Foster's last day with Proto Labs, Inc.?

Robert W. Foster will remain with Proto Labs, Inc. until June 14, 2024.

What is the date of this Form 8-K filing?

The Form 8-K filing is dated May 23, 2024.

What was the primary reason for this Form 8-K filing?

The primary reason for this filing is the departure of a director or certain officer, specifically the Chief Financial Officer.

Is Robert W. Foster leaving Proto Labs, Inc. immediately?

No, Robert W. Foster will remain with the company until June 14, 2024, to facilitate a smooth transition.

Filing Stats: 784 words · 3 min read · ~3 pages · Grade level 10.8 · Accepted 2024-05-24 16:11:18

Key Financial Figures

  • $0.001 — ich registered Common Stock, Par Value $0.001 Per Share PRLB New York Stock Exchange

Filing Documents

07. Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders. The Company held its Annual Meeting of Shareholders on May 23, 2024 (the "Annual Meeting"). At the Annual Meeting, the Company's shareholders elected all eight persons nominated by the Company's board of directors to serve as directors until the next Annual Meeting of Shareholders or until their successors are elected and duly qualified. The Company's shareholders also ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, approved an advisory vote on the compensation of the Company's executive officers and approved the Amended and Restated Proto Labs, Inc. 2022 Long-Term Incentive Plan. Set forth below are the final voting results for each of the proposals. Proposal 1. Election of Directors. Name For Against Abstain Broker Non-Votes Robert Bodor 19,320,598 230,225 9,903 2,524,059 Archie C. Black 16,982,982 2,565,194 12,550 2,524,059 Sujeet Chand 17,286,158 2,262,210 12,358 2,524,059 Moonhie Chin 17,592,740 1,955,566 12,420 2,524,059 Rainer Gawlick 18,990,298 558,232 12,196 2,524,059 Stacy Greiner 19,338,537 209,882 12,307 2,524,059 Donald G. Krantz 17,677,021 1,872,899 10,806 2,524,059 Sven A. Wehrwein 18,415,592 1,132,676 12,458 2,524,059 Proposal 2. Ratification of the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. For Against Abstain Broker Non-Votes 21,837,968 200,290 46,527 — Proposal 3. Advisory approval of executive compensation. For Against Abstain Broker Non-Votes 16,941,622 2,567,395 51,709 2,524,059 Proposal 4. Approval of the Amended and Restated Proto Labs, Inc. 2022 Long-Term Incentive Plan. For Against Abstain Broker Non-Votes 19,080,565 433,760 46,401 2,524,059 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.